Assessment of drug use among pregnant women in Addis Ababa, Ethiopia

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 6, 2009, Pages 462-468

  Kebede, Binyam ^a   Gedif, Teferi ^a   Getachew, Ashebir ^b  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

^b ADDIS ABABA UNIVERSITY   (Ethiopia)

Author keywords

Drug use; FDA risk classification; Herbal drugs; Over the counter; Pregnancy; Prescription

Indexed keywords

ALUMINUM HYDROXIDE; AMOXICILLIN; ANALGESIC AGENT; ANTACID AGENT; ANTIASTHMATIC AGENT; ANTIDIABETIC AGENT; ANTIEMETIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; ANTIULCER AGENT; ANTIVIRUS AGENT; CHLORPROMAZINE; DERMATOLOGICAL AGENT; FOLIC ACID; HERBACEOUS AGENT; INSULIN; IRON; METOCLOPRAMIDE; NON PRESCRIPTION DRUG; NYSTATIN; PARACETAMOL; PSYCHOTROPIC AGENT; SEX HORMONE; THYROXINE; UNINDEXED DRUG; VITAMIN; ANTIANEMIC AGENT; PLANT MEDICINAL PRODUCT;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG EXPOSURE; DRUG USE; EDUCATION; ETHIOPIA; FEMALE; FETUS RISK; HEALTH CARE PERSONNEL; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MARRIAGE; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SELF MEDICATION; DRUG UTILIZATION; PREGNANCY; PRESCRIPTION; STATISTICS;

ADULT; ANTI-BACTERIAL AGENTS; CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; DRUG UTILIZATION; ETHIOPIA; FEMALE; HEMATINICS; HUMANS; IRON; PLANT PREPARATIONS; PREGNANCY; PRENATAL CARE; QUESTIONNAIRES; SELF MEDICATION; VITAMINS;

EID: 68149098922     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1732     Document Type: Article

References (45)

1. Lagoy CT, Joshi N, Cragan JD, Rasmussen SA. Medication use during pregnancy and lactation: an urgent call for public health action. J Women's Health 2005; 14: 104-109.
2. Lee E, Maneno MK, Smith L, et al. National patterns of medication use during pregnancy Pharmacoepidemiol Drug saf. 2006; 15: 537-545.
3. Cragan JD, Friedman JM, Holmes LB, Uhl K, Green NS, Riley L. Ensuring the safe and effective use of medications during pregnancy: planning and prevention through preconception care. Matern Child Health J 2006; 10: 129-135.
4. Cunningham GF, MacDonald PC, Leveno KJ, Gant NF, Gilstrap LC. Williams Obstetrics, (22nd edn), McGraw Hill: New York, 2005; pp. 341-371.
5. Bar J, Hod M, Merlob P. Angiotensin converting enzyme inhibitor use in the first trimester of pregnancy. Int Risk Safety Med 1997; 10: 23-25.
6. Olesen C, Steffensen FH, Nielsen GL, Den Berg J, Olsen J, Sorensen HT. The Euromap group. Drug use in first pregnancy and lactation: a population-based survey among Danish women. Eur J Clin Pharmacol 1999; 55: 139-144.
7. Food and Drug Administration. FDA categories for drug use in pregnancy. Federal Register 1980; 44: 37434-37467.
8. WHO Collaborating Center for Drug Statistics Methodology). ATC index with DDDs. World Health Organization, Oslo, 2000.
9. Physicians' Desk Reference (PDR). Montvale, NJ: Medical Economics, 2004.
10. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal risk, (7th edn), Baltimore (MD): Williams & Wilkins, 2005.
11. Bonati M, Bortolus R, Marchetti F, Romer M, Tognoni G. Drug use in pregnancy: an overview of epidemiological (drug utilization) studies. Eur J Clin Pharmacol 1990; 38: 325-328.
12. Headley J, Northstone K, Simmons H, Golding J. Medication use during pregnancy: data from the Avon Longitudinal Study of Parents and Children. Eur J Clin Pharmacol 2004; 60: 355-361.
13. Collaborative group on drug use in pregnancy (CGDUP). Medication during pregnancy: an intercontinental cooperative study. Int J Gynecol Obstet 1992; 39: 185-196.
14. Aviv RI, Chubb K, Lindow SW. The prevalence of maternal medication ingestion in the antenatal period. S Afr Med J 1993; 83(9): 657-660.
15. Donati S, Baglio G, Spinelli A, Grandolfo ME. Drug use in pregnancy among Italian women. Eur J Clin Pharmacol 2000; 56: 323-328.
16. Rubin PC, Craig GF, Gavin K, Sumner D. Prospective survey of use of therapeutic drugs, alcohol, and cigarettes during pregnancy. Br Med J 1986; 292: 81-83.
17. Rubin JD, Ferencz C, Loffredo C. The Baltimore-Washington infant study group. Use of prescription and non - prescription drugs in pregnancy. J Clin Epidemiol 1993; 46(6): 581-589.
18. Schirm E, Meijer WM, Tobi H, de Jong-van den Berg L. Drug use by pregnant women and comparable non-pregnant women in the Netherlands with reference to the Australian classification system. Eur J Obstet Gynecol Reprod Biol 2004; 114: 182-188.
19. Riley EH, Afflick EF, Jackson RA, et al. Correlates of prescription drug use during pregnancy. J Women's Health 2005; 14(5): 401-409.
20. Nordeng H, Eskild A, Nesheim BI, Aursnes I, Jacobsen G. Drug use in pregnancy among parous Scandinavian women. Norwegian J Epidemiol 2001; 11(1): 97-103.
21. Doering PL, Boothby LA, Cheok M. Review of pregnancy labeling of prescription drugs: is the current system adequate to inform of risks? Am J Obstet Gynecol 2002; 187(2): 333-339.
22. Hardy JR, Leaderer BP, Holford TR, Hall GC, Bracken MB. Safety of medications prescribed before and during early pregnancy in a cohort of 81 975 mothers from the UK general practice research database. Pharmacoepidemiol Drug Saf 2006; 15: 555-564.
23. Andrade ES, Gurwitz JH, Davis RL, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol 2004; 191: 398-407.
24. Andrade ES, Raebel MA, Morse AN, et al. Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiol Drug Saf 2006; 15: 546-554.
25. Hernandez-Diaz S. Prescription of medications during pregnancy: accidents, compromises, and uncertainties. Pharmacoepidemiol Drug Saf 2006; 15: 613-617.
26. McElhatton PR. General principle of drug use in pregnancy. Pharmaceutical J 2003; 270: 232-234.
27. Goodman LS, Gilman AG. The Pharmacological Basis of Therapeutics, (5th edn), Macmillan: New York, 1975; pp 347-348.
28. FDA. List of products that have been withdrawn or removed from the market for reasons of safety or effectiveness. Food and Drug Administration. Fed Regist 1998; 63: 54082-54089.
29. Weintraub A, Mankuta D. Dipyron-induced oligohydramnios and ducts arteriosus restriction. IMAJ 2006; 8: 722-723.
30. Federal Ministry of Health, Planning and Programming Department. Health and Health Related Indicators (2005/6). Addis Ababa, Ethiopia, 2006.
31. Irl C, Kipferler P, Hasford J. Drug use assessment and risk evaluation in pregnancy - the Pegasus-project. Pharmacoepidemiol Drug saf 1997; 6(3): 37-42.
32. Refuerzo JS, Blackwell SC, Sokol RJ, et al. Use of over- the- counter medications and herbal remedies in pregnancy. Am J Perinatol 2005; 22(6): 321-324.
33. Glover DD, Amonkar M, Rybeck BF, Tracy TS. Prescription, over the counter, and herbal medicine use in a rural, obstetric population. Am J Obstet Gynecol 2003; 188(4): 1039-1045.
34. Black RA, Hill DA. Over the counter medications in pregnancy. Am Fam Physician 2003; 67(12): 2517-2524.
35. Abegaz B. Progress in the chemistry of marketed traditionally used plants of Ethiopia. Bull Chem Soc Ethiopia 1996; 10(1): 57-71.
36. Royal College of Obstetricians and Gynecologists (RCOG). Herbal medicinal products during pregnancy: are they safe? Br J Obstet Gynaecol 2002; 109: 227-235.
37. Abebe D, Debella A, Urga K. Illustrated Checklist of Medicinal Plants and Other Useful Plants of Ethiopia. National Health and Nutrition Research Institute: Addis Ababa, Ethiopia, 2003.
38. Zeichen R, Rey A, Arganaraz E, Bindstein E. Perinatal toxicology of Ruta Chalepensis (Rutaceae) in mice. J Ethnopharmacol 2000; 69(2): 93-98.
39. Ciganda C, Labored A. Herbal infusions used for induced abortion. J Toxicol Clin Toxicol 2003; 41(3): 235-239.
40. Adebiyi A, Adalkan PG, Prasad RNV. Pregnancy outcome following pre- and post- implantation exposure of Sprague-Damley rats to benzyl isothiocyanate. Food Chem Toxicol 2004; 42(5): 715-720.
41. Sharief M, Gani ZH. Garden cress (Lepidium sativum) seeds as oral contraceptive plant in mice. Saudi Med J 2004; 25(7): 965: URL: http://www.smj.org.sa
42. Yue QY, Jansson K. Herbal drug curbicin and anticoagulant effect with and without warfarin: possibly related to the vitamin E component. J Am Geriatr Soc 2001; 49: 838.
43. Chuang CH, Doyel P, Wang JD, Chang PJ, Lia JN, Chen PC. Herbal medicines used during the first trimester and major congenital malformations: an analysis of data from a pregnancy cohort study. Drug Saf 2006; 29(6): 537-548.
44. Ernst E. Herbal medicinal products during pregnancy: are they safe? Br J Obstet Gynaecol 2002; 109: 227-235.
45. Nielsen GL, Sorensen HT, Larsen H, Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal antiinflammatory drugs: population-based observational study and casecontrol study. Br Med J 2001; 322: 266-270.